Shares of the drugmaker plunge following an unexpected rejection of its key cancer drug and a slide in profit. But don't panic.
* UK study doesn't show survival gain seen in earlier trial * Merck KGaA shares down 3 percent, erasing earlier gains * Merck oncology head says UK study result "surprising" BERLIN, Sept 23 - Colon...
* Q4 core oper. profit down 29 percent, missing forecasts * FY liquid crystal margin falls further than expected * Swings to net loss on Raptiva drug charges * Says giving 2009 outlook would be...
Merck KGaA of Darmstadt, Germany has licensed the right to manufacture Stimuvax from Oncothyreon - a biotech company focussing on oncology products...
*Merck KGaA Q3 results *Due on Oct. 27 *Opg profit seen up 6.2 percent at 310 million euros ($410.6 million) FRANKFURT, Oct 21 - Germany's Merck KGaA, the world's largest maker of liquid crystals for...
Merch KGaA, a German-based chemical and pharmaceutical company, will spend over EUR 150 million to set up a clinical research and development hub in Beijing, according to the company spokesman Gangolf Schrimpf.The new center will be the fourth R&D hub in the German company's R&D global network. It...
* International study shows survival gain, UK study doesn't * Merck KGaA shares turn negative, erasing earlier gains * Merck oncology head says UK study result "surprising" * Merck, Lilly, Bristol drug competes with Amgen's...
* International study shows survival gain, UK study doesn't * Merck KGaA executive says UK study result "surprising" * Merck, Lilly, Bristol drug competes with Amgen's Vectibix BERLIN, Sept 23 - Colon cancer drug Erbitux...
* EU panel advises against use of drug for lung cancer * Merck says goal of 1 bln eur in Erbitux sales delayed * Q2 EBIT down 42 percent, missing forecasts * Sees recovery in...